Skip to main content
Log in

Long-term clonidine effects on autonomic function in essential hypertensive man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Acute studies of clonidine suggest that it lowers blood pressure by central enhancement of baroreflex sensitivity coupled with diminished evidence of sympathetic outflow, but longterm clonidine data have not been conclusive. We examined effects of one month of low dose clonidine (0.4 ± 0.15 mg/day) alone in 13 essential hypertensive men, assessing several biochemical indices of sympathetic function, as well as physiologic parameters, including baroreflex sensitivity, the cold pressor test, and the hypotensive response to alpha adrenergic blockade. Clonidine diminished mean arterial pressure (from 104±5 to 84±3 mmHg;p<0.01), without associated changes in several biochemical parameters of sympathetic outflow (urinary excretion of catecholamines, metanephrines, and vanillylmandelic acid; allp>0.1). Circulatory baroreflex function was not enhanced by clonidine, during either the amylnitrite test or the phenylephrine test, before or after parasympathetic blockade with atropine. The cold pressor test, an index of efferent sympathetic pressor function, was also unaltered. The enhanced mean arterial pressure response to phentolamine during clonidine therapy (from a fall of 14.8±4.3 to 39.4±5.2 mmHg,p<0.01), suggested an increase in alpha adrenergic vascular tone, perhaps mediated by clonidine's alpha agonist properties in vascular smooth muscle. The antihypertensive mechanism of longterm low dose clonidine cannot reliably be ascribed either to baroreflex enhancement or to suppression of sympathetic outflow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schmitt H, Schmitt H (1969) Localization of the hypotensive effect of 2-(2-6-dichlorophenyl-amino)-2-imidazole hydrochloride (St 155, catapresan). Eur J Clin Pharmacol 6: 8–12

    Google Scholar 

  2. Haeusler G (1974) Clonidine-induced inhibition of sympathetic nerve activity; no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch Pharmacol 286: 97–111

    Google Scholar 

  3. Van Zwieten PA (1973) The central action of antihypertensive drugs mediated via central α-receptors. J Pharm Pharmacol 25: 89–95

    Google Scholar 

  4. Hokfelt B, Hedeland H, Hansson B (1975) The effect of clonidine and penbutolol respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch Int Pharmacodyn Ther 213: 307–321

    Google Scholar 

  5. Wing L, Reid J, Hamilton C, Sever P, Davies DS, Dollery CT (1977) Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. Clin Sci Mol Med 53: 45–53

    Google Scholar 

  6. Metz S, Halter J, Porte D, Robertson (1978) Autonomic epilepsy: Clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med 88: 189–193

    Google Scholar 

  7. Sleight P, West MJ (1975) The effects of clonidine on the baroreflex arc in man. In: Davies DS, Reid JL (eds) Central action of drugs in blood pressure regulation. University Park Press, Baltimore

    Google Scholar 

  8. Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension: practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol 29: 633–640

    Google Scholar 

  9. Johnson RH, Spalding JMK (1974) Disorders of the autonomic nervous system. Blackwell Scientific Publications, FA Davis Co., Philadelphia, PA, pp 1–22

    Google Scholar 

  10. Thomson PD, Melmon KL (1968) Clinical assessment of autonomic function. Anesthesiology 29: 724–731

    Google Scholar 

  11. Lilley JJ, Golden J, Stone RA (1976) Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 57: 1190–1200

    Google Scholar 

  12. Levy SB, Lilley JJ, Stone RA (1978) Baroreflex function in uremic and hypertensive man. Am J Med Sci 276: 57–66

    Google Scholar 

  13. Levy SB, Lilley JJ, Stone RA (1978) Circulatory reflex abnormalities in chronic renal failure: relationship to uremic hypertension. Cardiovasc Med 3: 675–682

    Google Scholar 

  14. Smyth HS, Sleight P, Pickering G (1969) Reflex regulation of arterial pressure during sleep in man: quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109–121

    Google Scholar 

  15. Greene MA, Boltax AJ, Lustig GA, Rogow E (1965) Circulatory dynamics during the cold pressor test. Am J Cardiol 16: 54–60

    Google Scholar 

  16. Simon G, Kiowski W, Julius S (1978) Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol 22: 293–298

    Google Scholar 

  17. Jose AD, Taylor RR (1969) Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 48: 2019–2031

    Google Scholar 

  18. Esler M, Julius S, Zweifler, A, Randall O, Harburg E, Gardiner H, de Quattro V (1977) Mild high renin essential hypertension: neurogenic human hypertension? N Engl J Med 296: 405–411

    Google Scholar 

  19. Drayer JIM, Weber MA, Atlas SA, Laragh JH (1977) Phentolamine testing for alpha adrenergic participation in hypertensive patients: Independence from renin profiles. Clin Pharmacol Ther 22: 286–292

    Google Scholar 

  20. Esler MD, Julius S, Randall OS, Ellis CN, Kashima T (1975) Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol 36: 708–715

    Google Scholar 

  21. Hilliard CC, Bagwell EE, Daniell HB (1972) Effects of sympathetic and central nervous alterations on the blood pressure responses to phentolamine. J Pharmacol Exp Ther 180: 743–747

    Google Scholar 

  22. Crout JR, Pisano JJ, Sjoerdsma A (1961) Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Am Heart J 61: 375–381

    Google Scholar 

  23. Pisano JJ, Crout JR, Abraham D (1962) Determination of 3-methoxy-4-hydroxy-mandelic acid in urine. Clin Chim Acta 7: 285

    Google Scholar 

  24. Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotension I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349–1355

    Google Scholar 

  25. Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein activity and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 60: 129–138

    Google Scholar 

  26. Bliss CI (1970) Statistics in biology. McGraw-Hill, New York, p 558

    Google Scholar 

  27. Hőkfelt B, Hedeland H, Dymling J-F (1970) Studies on catecholamines, renin, and aldosterone following catapresan (2-(2,6-dichlor-phenyl-amine)-2-imidazoline hydrochloride) in hypertensive patients. Eur J Pharmacol 10: 389–397

    Google Scholar 

  28. Reid JL, Wing LMH, Dargie HJ, Hamilton CA, Davies DS, Dollery CT (1977) Clonidine withdrawal in hypertension. Lancet 1: 1171–1174

    Google Scholar 

  29. Cavins S, Marshall A (1976) Clonidine withdrawal. Lancet 1: 368

    Google Scholar 

  30. Moore M, Phillipi P (1976) Clonidine overdose. Lancet 2: 694

    Google Scholar 

  31. Frolich J (1976) Symptoms of clonidine withdrawal after 17 days. N Engl J Med 295: 1261–1261

    Google Scholar 

  32. Yudkin J (1977) Withdrawal of clonidine. Lancet 1: 546

    Google Scholar 

  33. MacFaul R, Miller G (1977) Clonidine poisoning in children. Lancet 1: 1266–1267

    Google Scholar 

  34. Hansson L, Hunyor SN, Julius S, Hoobler SW (1973) Blood pressure crisis following withdrawal of clonidine (catapres, catapresan) with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J 85: 605–610

    Google Scholar 

  35. DeChamplain J (1977) The sympathetic system in hypertension. Clin Endocrinol Metab 6: 633–655

    Google Scholar 

  36. Reid IA, MacDonald DM, Pachnis B, Ganong WF (1975) Studies concerning the mechanism of suppression of renin secretion by clonidine. J Pharmacol Exp Ther 192: 713–721

    Google Scholar 

  37. Pettinger WA, Keeton TK, Campbell WB, Harper DC (1976) Evidence for a renal alpha adrenergic receptor inhibiting renin release. Circ Res 38: 338

    Google Scholar 

  38. Chevillard C, Pasquier R, Duchene N, Alexandre JM (1978) Mechanism of inhibition of renin release by clonidine in rats. Eur J Pharmacol 48: 451–454

    Google Scholar 

  39. Vandongen R, Greenwood DM (1975) The inhibition of renin secretion in the isolated rat kidney by clonidine hydrochloride (Catapres). Clin Exp Pharmacol Physiol 2: 583–588

    Google Scholar 

  40. Gribbin B, Pickering TG, Sleight P, Seto R (1971) Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424–431

    Google Scholar 

  41. Takeshita A, Tanaka S, Kuriowa A, Nakamura M (1975) Reduced baroreceptor sensitivity in borderline hypertension. Circulation 51: 738–742

    Google Scholar 

  42. Haeusler G (1973) Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch Pharmacol 278: 231–246

    Google Scholar 

  43. Mancia G, Ferrari A, Gregorini L, Zanchetti A (1979) Clonidine and carotid baroreflex in essential hypertension. Hypertension 1: 362–370

    Google Scholar 

  44. Pickering TG, Gribbin B, Petersen ES, Cunningham DJC, Sleight P (1972) Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res 30: 177–185

    Google Scholar 

  45. Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39–100

    Google Scholar 

  46. Medgett IC, McCulloch MW, Rand MJ (1978) Partial agonist action of clonidine on prejunctional and postjunctional α-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 304: 215–221

    Google Scholar 

  47. Wing LMH, Reid JL, Davies DS, Dargie HJ, Dollery CT (1977) Apparent resistance to the hypotensive effect of clonidine. Br Med J 1: 136–138

    Google Scholar 

  48. Wilson IM, Freis ED (1959) Relationship between plasma and ecf volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20: 1028–1036

    Google Scholar 

  49. Conway J, Lauwers P (1960) Hemodynamic and hypotensive effects of longterm therapy with chorothiazide. Circulation 21: 21–27

    Google Scholar 

  50. Lund-Johansen P (1974) Hemodynamic changes at rest and during exercise in longterm clonidine therapy of essential hypertension. Acta Med Scand 195: 111–115

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Veterans Administration, and by a grant (HL-18095) from the National Institutes of Health Presented, in part, at the annual meeting of the Western Section, American Federation for Clinical Research, Carmel, CA, February, 1979. Clin. Res 27 (1): 15A, 1979

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, I.M., O'Connor, D.T., Preston, R.A. et al. Long-term clonidine effects on autonomic function in essential hypertensive man. Eur J Clin Pharmacol 19, 25–32 (1981). https://doi.org/10.1007/BF00558378

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558378

Key words

Navigation